01:15:56 EDT Thu 01 Jun 2023
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Titan Medical Inc (2)
Symbol TMD
Shares Issued 111,890,707
Close 2022-12-12 C$ 0.94
Recent Sedar Documents

Titan Medical receives user interface patent

2022-12-13 09:43 ET - News Release

Mr. Cary Vance reports

TITAN MEDICAL GRANTED PATENT COVERING USER EXPERIENCE, FURTHER ENHANCING ITS INTELLECTUAL PROPERTY IN ROBOTIC ASSISTED SURGERY

The United States Patent and Trademark Office (USPTO) recently issued patent No. 11,504,191, titled "Graphical User Interface for a Robotic Surgical System," to Titan Medical Inc. The patent, directed at enhancing the surgeon user experience, generally covers a graphical user interface (GUI) overlay of a surgical workspace to track instrument movement.

"The granting of this patent is a result of our strategic plan to independently build and protect a robust patent portfolio in robotic-assisted surgery, including around the Enos robotic single-access surgical system. Today's news validates our commitment to the continuum of innovation in robotic-assisted surgery," stated Cary Vance, president and chief executive officer of Titan. "Along with recent patent application filings, including some that have recently published, this patent demonstrates the company's focus on being an innovation leader in single-access RAS. The technology covered in this patent could assist with early-stage artificial intelligence that works to limit movement of instruments, including movements based on patient anatomy or more general keep-out zones, as well as enhancements in single-access RAS beyond the Enos system, including next-generation single-access RAS technologies and systems. We believe the breadth and depth of our patent portfolio provides us with options for monetization or other strategic opportunities."

The granted patent covers technology that generates a three-dimensional boundary for instruments within the surgical workspace, based on movement generated by a user-controlled hand controller. It also covers technology that provides the surgeon user the ability to limit instrument movement based on a two-dimensional projection of the instrument's position on the surgeon's screen based on visual data, as well as preoperative patient imaging or scans, or other patient specific data embodying one or more keep-out zones.

Titan has developed an expansive intellectual property portfolio with over 225 pending and issued patents covering the United States and other jurisdictions that support and cover various aspects of single-access RAS, including the Enos system's surgeon workstation, patient cart, dexterous articulating instruments, ergonomic hand controllers, enhanced vision systems, advanced control software and instinctive surgeon overlays for providing interoperative feedback. This coverage may provide the company with multiple intellectual property options, including further protecting its RAS technologies, and the potential to further license its technologies and secure strategic options.

About Titan Medical Inc.

Titan Medical, a medical device company headquartered in Toronto, Ont., with operations in Chapel Hill, N.C., is focused on enhancing robotic-assisted surgery using innovative technology through a single-access point. The Enos robotic single-access surgical system is being developed with an ergonomic focus to provide a surgical experience that imitates real-life movements that surgeons demand and includes multiarticulating instruments designed to allow surgeons an increased range of motion in a confined space, with dexterity and the ability to exert the forces necessary to complete common surgical tasks. With the Enos system, Titan intends to initially pursue gynecologic surgical indications.

We seek Safe Harbor.

© 2023 Canjex Publishing Ltd. All rights reserved.